双膦酸盐治疗长达20年对人松质骨杨氏模量和硬度的影响
研究对86例连续口服双膦酸盐1.1至20年的骨质疏松高加索女性髂嵴骨样本行组织学评估和纳米压痕测试,发现杨氏模量在治疗前6年增加、之后不再增加;硬度在治疗12.4年达峰后7.6年内保持恒定,其临床相关性尚不清楚。
要点
- 杨氏模量在双膦酸盐治疗1至6年间增加,6至20年间不再增加。
- 硬度在治疗12.4年达峰,随后7.6年治疗期内保持恒定。
- 硬度变化的临床相关性仍不明确。
核心结论
- 骨杨氏模量随双膦酸盐治疗时长增加至6年,治疗6年后无进一步模量增加。
- 硬度虽增加并于治疗12.4年达峰、随后7.6年保持恒定,但其临床相关性仍不明确。
研究设计与样本
- 研究为连续病例系列,纳入86例持续口服双膦酸盐1.1至20年的骨质疏松高加索女性,取髂嵴骨样本行组织学评估骨转换,并用纳米压痕测试杨氏模量和硬度,通过统计模型分析其与治疗时长的关系。
主要发现
- 所有骨样本均呈低骨转换。
- 统计模型显示杨氏模量和硬度随双膦酸盐治疗时长增加先升高、达峰后进入平台期。
- 模型以二次项描述治疗1至6年的模量增加,以线性项描述治疗6至20年的模量平台。
- 二次-线性转折点(join point)对应的治疗时长亦取决于小梁位置。
- 硬度在治疗12.4年达峰,随后7.6年治疗期内保持恒定,且对小梁位置不敏感。
关键数值与推荐
- 杨氏模量增加对应双膦酸盐治疗1至6年,平台对应治疗6至20年。
- 硬度峰值出现在治疗12.4年,其后7.6年治疗期内保持恒定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Bone modulus from patients with osteoporosis treated with bisphosphonates for 1 to 20 years was analyzed. Modulus increases during the first 6 years of treatment and remains unchanged thereafter. INTRODUCTION: Bisphosphonates are widely used for treating osteoporosis, but the relationship between treatment duration and bone quality is unclear. Since material properties partially determine bone quality, the present study quantified the relationship between human bone modulus and hardness with bisphosphonate treatment duration. METHODS: Iliac crest bone samples from a consecutive case series of 86 osteoporotic Caucasian women continuously treated with oral bisphosphonates for 1.1-20 years were histologically evaluated to assess bone turnover and then tested using nanoindentation. Young's modulus and hardness were measured and related to bisphosphonate treatment duration by statistical modeling. RESULTS: All bone samples had low bone turnover. Statistical models showed that with increasing bisphosphonate treatment duration, modulus and hardness increased, peaked, and plateaued. These models used quadratic terms to model modulus increases from 1 to 6 years of bisphosphonate treatment and linear terms to model modulus plateaus from 6 to 20 years of treatment. The treatment duration at which the quadratic-linear transition (join point) occurred also depended upon trabecular location. Hardness increased and peaked at 12.4 years of treatment; it remained constant for the next 7.6 years of treatment and was insensitive to trabecular location. CONCLUSIONS: Bone modulus increases with bisphosphonate treatment durations up to 6 years, no additional modulus increases occurred after 6 years of treatment. Although hardness increased, peaked at 12.4 years and remained constant for the next 7.6 years of BP treatment, the clinical relevance of hardness remains unclear.
引用
- Pienkowski D, Wood CL, Malluche HH, et al. Young's modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years. Osteoporos Int. 2018. PMID: 30488274. doi:10.1007/s00198-018-4760-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。